News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Salipro Biotech and Sumitomo Pharma Announce Collaboration to Advance Drug Discovery Program
Wednesday, September 13, 2023Swedish biotechnology company Salipro Biotech AB has announced a collaborative research effort with Sumitomo Pharma Co Ltd The primary objective of this collaboration is to elucidate the mechanism of action and characterize the pharmacological proper...
Neurocrine Biosciences, Partnering With Sosei Heptares, Launches Phase 1 Clinical Study to Investigate NBI-1117570 Effects in Healthy Adults
Tuesday, September 12, 2023Sosei Group Corporation TSE has been informed by its partner Neurocrine Biosciences Inc Nasdaq NBIX a prominent neurosciencefocused biopharmaceutical firm that it has initiated a Phase clinical study to assess the safety tolerability pharmacokineti...
Hillstream Enters Exclusive Option Agreement for Acquisition of Clinical-stage Therapy Addressing Chronic Pruritis
Tuesday, September 12, 2023Hillstream BioPharma Inc Nasdaq HILS is a biotechnology firm with a focus on developing therapeutic candidates to combat drugresistant cancers
Verona Pharma Receives FDA Acceptance for New Drug Application of Ensifentrine as COPD Maintenance Treatment
Monday, September 11, 2023Verona Pharma trading on Nasdaq as VRNA has announced that the US Food and Drug Administration FDA has accepted the companys New Drug Application NDA for the maintenance treatment of chronic obstructive pulmonary disease COPD with ensifentrine
Tango Therapeutics a Collaborator of Medivir Has Obtained FDA Clearance to Commence the Phase 1/2 Clinical Study for TNG348
Monday, September 11, 2023Medivir AB NASDAQ Stockholm MVIR a pharmaceutical company with a focus on innovative cancer treatments addressing significant unmet medical needs has made an announcement today
Maat Pharma Secures European Medicines Agency Orphan Drug Designation for MaaT033, With a Focus on Enhancing Survival in Hematopoietic Stem Cell Transplantation Patients
Friday, September 08, 2023MaaT Pharma a clinicalstage biotechnology firm traded on EURONEXT under the symbol MAAT has announced that the European Medicines Agency EMA has granted orphan drug designation ODD for their product MaaT
Actimed Therapeutics Receives FDA Approval for Phase 2b/3 IMPACT Clinical Trials Evaluating S-pindolol Benzoate as a Treatment for Cancer Cachexia
Friday, September 08, 2023Actimed Therapeutics Ltd a UKbased pharmaceutical company with a focus on innovative treatments for cancer cachexia and muscle wasting disorders has received approval from the US FDA for its Investigational New Drug IND application
Myricx and Biocytogen Announce Antibody Licensing Partnership
Friday, September 08, 2023Myricx Bio a prominent UK biotech company specializing in the exploration and development of a groundbreaking class of selective cytotoxic payloads for antibody drug conjugates ADCs has announced a significant antibody license agreement with Biocytog...
Lupin, in Collaboration With Mark Cuban's Cost Plus Drug Company and the COPD Foundation, Aims to Improve Medication Accessibility for COPD Patients
Thursday, September 07, 2023Lupin Limited a global pharmaceutical company has formed a unique partnership with the Mark Cuban Cost Plus Drug Company Cost Plus Drugs and the COPD Foundation with the goal of improving healthcare access for COPD patients in the United States
FDA Approves Phase 2 Trial of RLS-0071 in Hospitalized Patients With Steroid-refractory Acute Graft-versus-host Disease by Realta Life Sciences
Thursday, September 07, 2023ReAlta Life Sciences Inc known as ReAlta is a clinicalstage biotechnology company that focuses on harnessing the immune systems potential to combat lifethreatening diseases
